IDN-5491

N/A

Report date: 2026/01/22 16:42:24

NME

Base Information

Drug NameIDN-5491

Drug Alias NameHyperforin trimethoxybenzoate

ClassificationSmall molecules

Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors

TargetsNuclear factor NF-kappa-B complexExtracellular-signal-regulated kinase1Extracellular-signal-regulated kinase 2

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIndena

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIndena

Active IndicationsN/A

Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A